ArticleFrontiers in immunology2026
Clinical variables and quantitative CT radiomics for mortality risk stratification after acute exacerbation of idiopathic inflammatory myopathy-associated interstitial lung disease.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute exacerbation (AE) is the most lethal event of idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-ILD). This exploratory study compared clinical, radiomics, and combined predictor strategies across five survival-learning algorithms for survival risk stratification. Methods: We retrospectively analyzed 78 patients with AE-IIM-ILD and divided them into a training cohort (n = 54; 20 deaths) and a held-out internal testing cohort (n = 24; 9 deaths), stratified by observed mortality event status. Three predictor strategies were evaluated: a clinical strategy comprising PaO Results: During the 1-year follow-up, 29 deaths were observed. Performance rankings varied across predictor strategies, algorithms, and evaluation metrics. The combined-Random Survival Forest configuration demonstrated the highest training-cohort C-index among the 15 configurations. Its mean time-dependent AUC was 0.923 (95% CI: 0.860-0.970) in the training cohort and 0.915 (95% CI: 0.736-0.986) in the testing cohort, with corresponding C-indices of 0.874 (95% CI: 0.803-0.940) and 0.842 (95% CI: 0.673-0.971), respectively. The model stratified patients into high- and low-risk groups with distinct observed survival trajectories. Conclusion: In this exploratory cohort, integrating selected clinical variables with a quantitative CT Rad-score using RSF showed promising numerical discrimination and risk-stratification performance. These findings suggest that clinical and quantitative imaging information may provide complementary prognostic information after AE-IIM-ILD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.